文献速递肺外科

1.5至2.0厘米临床IA2期非小细胞肺癌患者中亚肺叶切除与较少淋巴结检查及辅助治疗实施率较低相关:一项回顾性队列研究

Sublobar resection is associated with less lymph nodes examined and lower delivery of adjuvant therapy in patients with 1.5- to 2.0-cm clinical IA2 non-small-cell lung cancer: a retrospective cohort study.
PubMed 文献 · Eur J Cardiothorac Surg · 2024-01-01

基于美国国家癌症数据库(2018-2019年)的回顾性队列研究纳入3196例1.5-2.0厘米非小细胞肺癌患者,比较亚肺叶切除(839例,26.3%)与肺叶切除(2357例,73.7%)。亚肺叶切除组未采样淋巴结比例更高(21.7% vs 2.1%,P<0.001),检查淋巴结总数更少(4 vs 11,P<0.001),病理性淋巴结转移率更低(4.7% vs 9%,P<0.001)。多变量分析显示肺叶切除与病理性N+疾病独立相关(aOR 2.21,95%CI 1.47-3.35)。总生存与手术方式无关,但N+疾病患者生存显著降低。

要点

  • 亚肺叶切除组21.7%未采样淋巴结,肺叶切除组仅2.1%(P<0.001)。
  • 亚肺叶切除组检查淋巴结总数4枚,肺叶切除组11枚(P<0.001)。
  • 肺叶切除与病理性N+疾病独立相关(aOR 2.21,95%CI 1.47-3.35)。

核心结论

  • 尽管总生存与肺叶切除相当,亚肺叶切除在1.5-2.0厘米非小细胞肺癌患者中与淋巴结清扫不充分相关。
  • 外科医生在行亚肺叶切除时应仔细进行充分的淋巴结清扫,以减少淋巴结分期不足并识别适合系统治疗的患者。

研究设计与样本

  • 回顾性队列研究,使用美国国家癌症数据库(2018-2019年)数据。
  • 纳入3196例1.5-2.0厘米非小细胞肺癌接受切除术的患者,其中亚肺叶切除839例(26.3%,含588例楔形切除),肺叶切除2357例(73.7%)。
  • 采用逻辑回归分析淋巴结升级相关因素,Cox回归和Kaplan-Meier法分析生存,并行倾向性匹配调整组间差异。

主要发现

  • 亚肺叶切除组未采样淋巴结比例21.7%,肺叶切除组2.1%(P<0.001)。
  • 亚肺叶切除组检查淋巴结总数4枚,肺叶切除组11枚(P<0.001)。
  • 亚肺叶切除组病理性淋巴结转移率4.7%,肺叶切除组9%(P<0.001)。
  • 多变量分析显示肺叶切除与病理性N+疾病独立相关(aOR 2.21,95%CI 1.47-3.35)。
  • 总生存与手术方式无关,但N+疾病患者生存显著降低。

关键数值与推荐

  • 亚肺叶切除组未采样淋巴结比例21.7% vs 肺叶切除组2.1%(P<0.001)。
  • 亚肺叶切除组检查淋巴结总数4枚 vs 肺叶切除组11枚(P<0.001)。
  • 亚肺叶切除组病理性淋巴结转移率4.7% vs 肺叶切除组9%(P<0.001)。
  • 肺叶切除与病理性N+疾病独立相关(aOR 2.21,95%CI 1.47-3.35)。

临床怎么用

  • 外科医生在行亚肺叶切除时应仔细进行充分的淋巴结清扫,以减少淋巴结分期不足并识别适合系统治疗的患者。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: CALGB140503, in which nodal sampling was mandated, reported non-inferior disease-free survival for patients undergoing sublobar resection (SLR) compared to lobectomy (L). Outside of trial settings, the adequacy of lymphadenectomy during SLR has been questioned. We sought to evaluate whether SLR is associated with suboptimal lymphadenectomy, differences in pathologic upstaging and survival in patients with 1.5- to 2.0-cm tumours using real-world data. MATERIALS AND METHODS: Using the National Cancer Database(2018-2019), we evaluated patients with 1.5- to 2.0-cm non-small-cell lung cancer who underwent resection (sublobar versus lobectomy). We studied factors associated with nodal upstaging (logistic regression) and survival (Cox regression and Kaplan-Meier method) after propensity matching to adjust for differences among groups. RESULTS: Among 3196 patients included, SLR was performed in 839 (26.3%) (of which 588 were wedge resections) and L was performed in 2357 (73.7%) patients. More patients undergoing SLR (21.7%) compared to L (2.1%) had no lymph nodes sampled (P < 0.001). Those undergoing SLR had fewer total lymph nodes examined (4 vs 11, P < 0.001) and were less likely to have pathologic nodal metastases (4.7% vs 9%, P < 0.001) compared to L. Multivariable analysis identified L [adjusted odds ratio (aOR) 2.21, 95% confidence interval, 1.47-3.35] to be independently associated with pathologic N+ disease. Overall survival was not associated with the type of procedure but was significantly decreased in those with N+ disease. CONCLUSIONS: Despite comparable overall survival to L, SLR is associated with suboptimal lymphadenectomy in patients with 1.5-2.0 cm non-small-cell lung cancer. Surgeons should be careful to perform adequate lymphadenectomy when performing SLR to mitigate nodal under-staging and to identify appropriate patients for systemic therapy.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Rodriguez-Quintero JH, Kamel MK, Jindani R, et al. Sublobar resection is associated with less lymph nodes examined and lower delivery of adjuvant therapy in patients with 1.5- to 2.0-cm clinical IA2 non-small-cell lung cancer: a retrospective cohort study. Eur J Cardiothorac Surg. 2024. PMID: 38147358. doi:10.1093/ejcts/ezad431

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。